cbdMD (YCBD) Stock: Buy, Sell, or Hold?
YCBD - cbdMD, Inc. Common Stock
$0.48
0.00 (0.88%)
â˛
5d:
+0.25%
30d:
-19.36%
90d:
-30.92%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When YCBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: YCBD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: YCBD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: YCBD is currently trading at $0.48, which is considered slightly low relative to its 30-day fair value range of $0.48 to $0.55.
Technical Outlook: Technically, YCBD is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $0.52.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+314.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, YCBD is in a strong downtrend. Immediate support is located at $0.45, while resistance sits at $0.52.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+314.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.48 -
$0.55
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 314.8% below Wall St target ($2.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.48 -
$0.55
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.45
Resistance Level
$0.52
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.54
Wall Street Target
$2.00
(+314.8%)
Revenue Growth (YoY)
20.6%
Profit Margin
-13.8%
Share & Embed Analysis
Last updated: September 13, 2026 8:04 PM ET
Data refreshes hourly during market hours. Next update: 9:04 PM
Data refreshes hourly during market hours. Next update: 9:04 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YCBD showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences IâĻ |
STRONG BUY
25 analysts |
$211 | 60 HOLD |
|
LQDA
Liquidia Technologies Inc |
STRONG BUY
10 analysts |
$108 | 70 BUY |
|
INDV
Indivior PLC Ordinary ShâĻ |
STRONG BUY
7 analysts |
$49 | 69 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$108 | 46 HOLD |
|
UTHR
United Therapeutics CorpâĻ |
STRONG BUY
15 analysts |
$664 | 47 HOLD |
